Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon L Croft

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Antimicrobial Agents and Chemotherapy|December 25, 2019
Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana <i>In Vitro</i>Alaa Riezk, John G Raynes, Vanessa Yardley, et al.
Molecules (Basel, Switzerland)|September 5, 2020
Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous LeishmaniasisAlaa Riezk, Katrien Van Bocxlaer, Vanessa Yardley, et al.
Kinetoplastid Biology and Disease|April 26, 2007
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006Farrokh Modabber, Pierre A Buffet, Els Torreele, et al.
Journal of Medicinal Chemistry|October 18, 2002
Synthesis, stability, and antimalarial activity of new hydrolytically stable and water-soluble (+)-deoxoartelinic acidMankil Jung, Kyunghoon Lee, Howard Kendrick, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral LeishmaniasisAndrew A Voak, Andy Harris, Zeeshan Qaiser, et al.
Plos One|March 11, 2025
Comparative assessment of macrophage responses and antileishmanial efficacy in dynamic vs. Static culture systems utilizing chitosan-based formulationsAlaa Riezk, Alec O'Keeffe, Katrien Van Bocxlaer, et al.
Plos Neglected Tropical Diseases|September 20, 2019
Innovations for the elimination and control of visceral leishmaniasisAngamuthu Selvapandiyan, Simon L Croft, Suman Rijal, et al.
The Journal of Antimicrobial Chemotherapy|October 10, 2014
A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasisHollie Burrell-Saward, Jean Rodgers, Barbara Bradley, et al.
Plos One|July 25, 2019
Development of an in vitro media perfusion model of Leishmania major macrophage infectionAlec O'Keeffe, Lauren Hyndman, Sean McGinty, et al.
Nature Reviews. Drug Discovery|June 3, 2004
Antimalarial drug discovery: efficacy models for compound screeningDavid A Fidock, Philip J Rosenthal, Simon L Croft, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|December 25, 2019
Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana <i>In Vitro</i>Alaa Riezk, John G Raynes, Vanessa Yardley, et al.
Molecules (Basel, Switzerland)|September 5, 2020
Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous LeishmaniasisAlaa Riezk, Katrien Van Bocxlaer, Vanessa Yardley, et al.
Kinetoplastid Biology and Disease|April 26, 2007
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006Farrokh Modabber, Pierre A Buffet, Els Torreele, et al.
Journal of Medicinal Chemistry|October 18, 2002
Synthesis, stability, and antimalarial activity of new hydrolytically stable and water-soluble (+)-deoxoartelinic acidMankil Jung, Kyunghoon Lee, Howard Kendrick, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral LeishmaniasisAndrew A Voak, Andy Harris, Zeeshan Qaiser, et al.
Plos One|March 11, 2025
Comparative assessment of macrophage responses and antileishmanial efficacy in dynamic vs. Static culture systems utilizing chitosan-based formulationsAlaa Riezk, Alec O'Keeffe, Katrien Van Bocxlaer, et al.
Plos Neglected Tropical Diseases|September 20, 2019
Innovations for the elimination and control of visceral leishmaniasisAngamuthu Selvapandiyan, Simon L Croft, Suman Rijal, et al.
The Journal of Antimicrobial Chemotherapy|October 10, 2014
A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasisHollie Burrell-Saward, Jean Rodgers, Barbara Bradley, et al.
Plos One|July 25, 2019
Development of an in vitro media perfusion model of Leishmania major macrophage infectionAlec O'Keeffe, Lauren Hyndman, Sean McGinty, et al.
Nature Reviews. Drug Discovery|June 3, 2004
Antimalarial drug discovery: efficacy models for compound screeningDavid A Fidock, Philip J Rosenthal, Simon L Croft, et al.
Pageof 15